A Novel Bifunctional Hybrid Conjugate of 3-O-Methyl Ellagic Acid and Urolithin A via PEG₃ Linker: In Silico CDK2-Targeted Strategy for Lung Cancer Therapy. Pjmcr [Internet]. 2026 Apr. 30 [cited 2026 May 1];5(2):1193-200. Available from: https://pakjmcr.com/index.php/1/article/view/914